Clinical trials with MRNA electroporated dendritic cells for stage III/IV melanoma patients

Podobne zapisy

• Phase II study of autologous mRNA electroporated dendritic cells (TriMixDC-MEL) in combination with Ipilimumab in patients with pretreated advanced melanoma
  od: Thielemans, Kris, i wsp.
  Wydane: (2014)
• Characterization of CD8(+) T-Cell Responses in the Peripheral Blood and Skin Injection Sites of Melanoma Patients Treated with mRNA Electroporated Autologous Dendritic Cells (TriMixDC-MEL)
  od: Benteyn, Daphné, i wsp.
  Wydane: (2013)
• TriMix and tumor antigen mRNA electroporated dendritic cell vaccination plus ipilimumab: link between T-cell activation and clinical responses in advanced melanoma
  od: De Keersmaecker, Brenda, i wsp.
  Wydane: (2020)
• Dendritic Cells Loaded With mRNA Encoding Full-length Tumor Antigens Prime CD4(+) and CD8(+) T Cells in Melanoma Patients
  od: Van Nuffel, An MT, i wsp.
  Wydane: (2012)
• AZD1480 delays tumor growth in a melanoma model while enhancing the suppressive activity of myeloid-derived suppressor cells
  od: Maenhout, Sarah K., i wsp.
  Wydane: (2014)